Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
161 hedge funds and large institutions have $341M invested in Spectrum Pharmaceuticals Inc in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 57 increasing their positions, 42 reducing their positions, and 21 closing their positions.
36% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 42
1% more funds holding
Funds holding: 159 → 161 (+2)
10% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 21
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $380M → $341M (-$38.6M)
57% less call options, than puts
Call options by funds: $336K | Put options by funds: $778K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$15.3M |
| 2 |
AC
Armistice Capital
New York
|
+$8.31M |
| 3 |
BlackRock
New York
|
+$5.57M |
| 4 |
Two Sigma Investments
New York
|
+$2.96M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$4.09M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$3.06M |
| 3 |
Millennium Management
New York
|
-$2.13M |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$2.1M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$1.62M |
SPPI Hedge Fund Activity: Q4 2020 in Review
161 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2020, worth a combined $341M — down 10% from $380M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new SPPI positions and 21 closed out — a net gain of 2 holders — while 57 added to existing stakes and 42 trimmed.
The largest buyer was State Street, adding an estimated $15.3M. The largest seller was Renaissance Technologies, cutting an estimated $4.09M.
- 161 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2020, up from 159 in Q3 2020.
- Funds reported $341M of Spectrum Pharmaceuticals Inc stock for Q4 2020, down 10% quarter-over-quarter.
- 23 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2020 and 21 closed out, a net change of +2 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q4 2020 was State Street, an estimated $15.3M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q4 2020 was Renaissance Technologies, an estimated $4.09M sold.
Based on aggregated 13F filings for Q4 2020.